Zevra Therapeutics, Inc.ZVRANASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-87.00M
↓ 151% below average
Average (9y)
$-34.70M
Historical baseline
Range
High:$7.73M
Low:$-87.00M
CAGR
+16.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-87.00M | -75.4% |
| 2023 | $-49.60M | -16.5% |
| 2022 | $-42.56M | -650.7% |
| 2021 | $7.73M | +237.8% |
| 2020 | $-5.61M | +72.4% |
| 2019 | $-20.34M | +63.6% |
| 2018 | $-55.90M | -67.5% |
| 2017 | $-33.37M | +11.0% |
| 2016 | $-37.48M | -64.3% |
| 2015 | $-22.81M | - |